Masafumi Maruo
Papers
3
Total Citations
21
H-Index
3
About
Dr. Masafumi Maruo is a pioneering urologic surgeon whose work centers on refining robot-assisted radical prostatectomy (RARP) and advancing personalized treatment for aggressive genitourinary cancers. His most impactful contribution is the development of a novel nerve-sparing RARP technique that preserves the endopelvic fascia, demonstrating that it is possible to achieve excellent long-term oncological control (11 citations) while significantly improving post-surgical continence—a critical quality-of-life outcome for patients. Dr. Maruo’s research is distinguished by its integration of precision medicine; he reported the first pathological complete response in plasmacytoid variant bladder cancer—a notoriously aggressive and rare malignancy—using pembrolizumab guided by genomic analysis (6 citations). This case highlights his commitment to translating molecular insights into life-saving therapies. Furthermore, he has developed and validated a novel nomogram (4 citations) specifically for Japanese prostate cancer patients in the robotic era, enabling surgeons to accurately identify candidates for extended pelvic lymph node dissection and avoid unnecessary procedures. By combining surgical innovation with data-driven risk stratification and genomic-guided immunotherapy, Dr. Maruo is shaping a future where urologic oncology is both more effective and less invasive.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3